FISIOLOGÍA Y FARMACOLOGÍA
Departamento
Universidad de Alcalá
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Alcalá (7)
2023
-
Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis
Blood, Vol. 141, Núm. 4, pp. 406-421
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2016
2010
-
Targeted genomic disruption of H-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism
Hypertension, Vol. 56, Núm. 3, pp. 484-489
2007
-
Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-β signaling
Journal of Cellular Physiology, Vol. 210, Núm. 2, pp. 456-468
2002
-
Expression of endoglin in human mesangial cells: Modulation of extracellular matrix synthesis
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1587, Núm. 1, pp. 36-44
1997
-
Involvement of phospholipase A2 in gentamicin-induced rat mesangial cell activation
American Journal of Physiology - Renal Physiology, Vol. 273, Núm. 1 42-1